Cite
HARVARD Citation
Greene, J. et al. (n.d.). Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence. Journal for immunotherapy of cancer. p. . [Online].